Skip to main content

Table 1 Baseline characteristics

From: Clinical usefulness of early serial measurements of C-reactive protein as outcome predictors in patients with subarachnoid hemorrhage

 Favorable neurological outcome (n = 109)Poor neurological outcome (n = 47)P value
Age (yr) — mean ± SD56.6 ± 12.566.4 ± 12.2< 0.001
Gender, male — no. of patients (%)37 (33.9)14 (29.8)0.748
BMI (kg/m2) — mean ± SD23.6 ± 3.323.1 ± 5.20.576
Comorbidities — no. of patients (%)
 Hypertension36 (33.0)24 (51.1)0.052
 Current smoker25 (22.9)7 (14.9)0.355
 Diabetes mellitus5 (4.6)5 (10.6)0.289
 Dyslipidemia6 (5.5)0 (0)0.235
 Previous TIA or stroke3 (2.8)2 (4.3)0.999
 Malignancy2 (1.8)2 (4.3)0.745
 Chronic kidney disease3 (2.8)0 (0)0.608
 Ischemic heart disease2 (1.8)0 (0)0.874
Hunt and Hess Classification — no. of patients (%)  < 0.001
 269 (63.3)2 (4.3) 
 320 (18.3)7 (14.9) 
 413 (11.9)11 (23.4) 
 57 (6.4)27 (57.4) 
Glasgow Coma Scale — mean ± SD12.8 ± 3.57.1 ± 3.8< 0.001
Modified Fisher classification — no. of patients (%)  < 0.001
 125 (22.9)1 (2.1) 
 28 (7.3)0 (0) 
 357 (52.3)23 (48.9) 
 419 (17.4)23 (48.9) 
Pupil reactivity — no. of patients (%)  < 0.001
 Both intact pupil reflex100 (91.7)28 (59.6) 
 One unreactive pupil3 (2.8)3 (6.4) 
 Both unreactive pupils6 (5.5)16 (34.0) 
Aneurysm location — no. of patients (%)  0.036
 Anterior communicating artery33 (30.3)8 (17.0) 
 Anterior cerebral artery & distal3 (2.8)7 (14.9) 
 Middle cerebral artery & distal24 (22.0)12 (25.5) 
 Internal carotid artery6 (5.5)7 (14.9) 
 Posterior communicating artery20 (18.3)6 (12.8) 
 Posterior circulation12 (11.0)3 (6.4) 
 No aneurysm7 (6.4)3 (6.4) 
 Unknown4 (3.7)1 (2.1) 
Hydrocephalus — no. of patients (%)48 (44.0)34 (72.3)0.002
Intraventricular hemorrhage — no. of patients (%)25 (22.9)23 (48.9)0.002
  1. SD, standard deviation; BMI, body mass index; TIA, transient ischemic attack